BTA Exclusive share session featuring Daniel Schneider, Director, Global Precision Medicine Strategy – Hematology, Johnson & Johnson
Posts by:
Rare diseases affect millions globally, yet their small patient populations present enormous challenges for research. Recruiting participants for clinical trials can feel impossible, delaying progress and limiting options for those living with these conditions.
Recap and video of WHTW session featuring: Brittany Barreto, Advisory Board Member for Network of Excellence in Women’s Health,
CIO, Founder, Imperial College London, FemHealth Insights
The healthcare system is designed around objective lab tests for physical health, but mental health lacks similar standardized tools. This absence of objective measures makes ADHD diagnosis and treatment highly subjective, relying on inconsistent self-reports and parental feedback.
BTA Exclusive share session featuring Savan Devani, CEO, Biotrillion
BTA Exclusive share session featuring: Angie Laousek Ebrahimi, Senior Director, Lifestyle Medicine, Blue Shield California
